Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.74 |
| ▸ | HTT | P42858 | 3/20 | 0.74 |
| ▸ | POLB | P06746 | 5/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | CASP6 | P55212 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 7/20 | 0.66 |
| ▸ | MITF | O75030 | 4/20 | 0.66 |
| ▸ | RAB9A | P51151 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrofurazone SCHEMBL25417 | 1.00 | LMNA (1.00) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL3681048 | 1.00 | LMNA (1.00) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL28198181 | 0.99 | LMNA (0.97) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL28285714 | 0.97 | LMNA (0.94) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL9928793 | 0.93 | LMNA (0.87) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL20775188 | 0.93 | LMNA (0.87) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL28246849 | 0.91 | LMNA (0.83) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL9054779 | 0.91 | LMNA (0.83) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nitrofurazone SCHEMBL28871281 | 0.90 | LMNA (0.81) | LMNAALDH1A1CYP3A4CYP1A2KDM4E | |
| Nifuraldezone SCHEMBL193103 | 0.89 | LMNA (0.80) | LMNAALDH1A1CYP3A4CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14938 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011418-A | One-dimensional ring chain manganese coordination polymer and preparation method and application thereof | 青海民族大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4694929-A1 | METHODS FOR TREATING CORNEAL INJURIES | Lin, Sung-Jan (TW) | 2026-02-18 | — | — | EP | claimed |
| US-20260000646-A1 | Inhibition of Oral Microbe Biofilms | THE UNIVERSITY OF TOLEDO (US) | 2026-01-01 | — | — | US | claimed |
| EP-4630446-A1 | ENGINEERED SWITCHES FOR IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4630043-A1 | IMMUNE-ACTIVATING COMPLEXES | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| US-20250222066-A1 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2025-07-10 | — | — | US | claimed |
| EP-4101437-B1 | BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2025-06-11 | — | — | EP | claimed |
| CN-120004253-A | Preparation method of petal-shaped S, N-co-doped carbon nano-sheet loaded with hybrid magnetic nano-particles, and product and application thereof | 湖南科技大学 | 2025-05-16 | — | — | CN | claimed |
| EP-4547023-A2 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | University of Utah Research Foundation (US) | 2025-05-07 | — | — | EP | claimed |
| EP-0138740-A2 | Synthetic resin wound dressing and method of manufacturing | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1985-04-24 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| EP-0122709-A1 | Improvements in or relating to antibiotic or germicide layered implants | ELI LILLY AND COMPANY (US) | 1984-10-24 | — | — | EP | claimed |
| US-4478822-A | Drug delivery system utilizing thermosetting gels | MERCK & CO., INC. (US) | 1984-10-23 | — | — | US | claimed |
| US-4474752-A | DIAMINE MODIFIED POLYOXYETHYLENE-POLYOXYPROPYLENE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| US-4474753-A | POLYETHERAMINE | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| EP-0055023-A2 | Antiseptic containing adhesive composition | E.R. Squibb & Sons, Inc. (US) | 1982-06-30 | — | — | EP | claimed |
| US-4186184-A | Selective administration of drug with ocular therapeutic system | ALZA CORPORATION (US) | 1980-01-29 | — | — | US | claimed |
| US-4024871-A | POLYURETHANE | ETHICON, INC. (US) | 1977-05-24 | — | — | US | claimed |